Davis's Drug Guide
avutometinib/defactinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
a-vue-toe-me-ti-nib/dee-fak-ti-nib
Trade Name(s)
- Avmapki Fakzynja Co-Pack
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Avutometinib/defactinib." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580155/all/avutometinib_defactinib.
Vallerand AHA, Sanoski CAC. Avutometinib/defactinib. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580155/all/avutometinib_defactinib. Accessed August 5, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Avutometinib/defactinib. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580155/all/avutometinib_defactinib
Vallerand AHA, Sanoski CAC. Avutometinib/defactinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 05]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580155/all/avutometinib_defactinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - avutometinib/defactinib
ID - 3580155
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580155/all/avutometinib_defactinib
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -
